Classification
- Anatomical main groupBBlood and blood-forming organs
- Therapeutic subgroupB01
- Pharmacological subgroupB01A
- Chemical subgroupB01AX
- Chemical substanceB01AX05Fondaparinux
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Spain
AEMPS · 9 registrations
- Arixtra 1,5 MG/0,3 ML Solucion Inyectable, Jeringa Precargada1,5 mg · solución inyectable en jeringa precargada · Viatris Healthcare Limited
- Arixtra 2,5 MG/0,5 ML Solucion Inyectable, Jeringa Precargada2,5 mg · solución inyectable en jeringa precargada · Viatris Healthcare Limited · 2 entries
- Arixtra 2,5 MG/0,5 ML Solucion Inyectable, Jeringa Precargada2,5 mg · solución inyectable · Viatris Healthcare Limited
Canada
Health Canada · 8 registrations
At a glance
- ATC code
- B01AX05
- ATC group
- Blood and blood-forming organs
- Registers
- 10
- Historical lists
- 2
- Registrations
- 43
- With their own page
- 34
- Companies
- 17
All medicines with Fondaparinux
Human medicines from every register that match Fondaparinux by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
43 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Fondaparinux Sodium | United States | 10MG/0.8ML, 2.5MG/0.5ML, 5MG/0.4ML … | solution | Marketed | Hangzhou Zhongmei |
| Fondaparinux Sodium Injection | Canada | 2.5 MG / 0.5 ML | Solution | Marketed | DR Reddy'S Laboratories LTD |
| Fondaparinux Sodium Injection | Canada | 7.5 MG / 0.6 ML | Solution | Marketed | DR Reddy'S Laboratories LTD |
| Fondaparinux Sodium Injection | Canada | 5 MG / 0.4 ML | Solution | Authorised | DR Reddy'S Laboratories LTD |
| Fondaparinux Sodium Injection | Canada | 10 MG / 0.8 ML | Solution | Authorised | DR Reddy'S Laboratories LTD |
| Fondaparinux SPC 2.5MG/0.5ML Injection | Saudi Arabia | Authorised | Gland Pharma Limited | ||
| Arixtra | United States | 10MG/0.8ML, 2.5MG/0.5ML, 5MG/0.4ML … | solution | Marketed | Mylan Ireland LTD |
| Arixtra | European Union | Authorised | Viatris Healthcare Limited | ||
| Arixtra 2,5 MG/0,5 ML Solucion Inyectable, Jeringa Precargada | Spain | 2,5 mg | solución inyectable | Marketed | Viatris Healthcare Limited |
| Arixtra 2,5 MG/0,5 ML Solucion Inyectable, Jeringa Precargada | Spain | 2,5 mg | solución inyectable en jeringa precargada | Marketed | Viatris Healthcare Limited |
| Arixtra 2,5 MG/0,5 ML Solucion Inyectable, Jeringa Precargada | Spain | 2,5 mg | solución inyectable en jeringa precargada | Marketed | Viatris Healthcare Limited |
| Arixtra 2,5 MG/0,5 ML Solucion Inyectable, Jeringa Precargada | Spain | 2,5 mg | solución inyectable en jeringa precargada | Marketed | Viatris Healthcare Limited |
| Arixtra 2,5 MG/0,5 ML Solucion Inyectable, Jeringa Precargada | Spain | 2,5 mg | solución inyectable en jeringa precargada | Marketed | Viatris Healthcare Limited |
| Arixtra 5 MG/0,4 ML Solucion Inyectable, Jeringa Precargada | Spain | 5 mg | solución inyectable en jeringa precargada | Marketed | Viatris Healthcare Limited |
| Arixtra 1,5 MG/0,3 ML Solucion Inyectable, Jeringa Precargada | Spain | 1,5 mg | solución inyectable en jeringa precargada | Marketed | Viatris Healthcare Limited |
| Arixtra 7,5 MG/0,6 ML Solucion Inyectable, Jeringa Precargada | Spain | 7,5 mg | solución inyectable en jeringa precargada | Marketed | Viatris Healthcare Limited |
| Arixtra 7,5 MG/0,6 ML Solucion Inyectable, Jeringa Precargada | Spain | 7,5 mg | solución inyectable en jeringa precargada | Marketed | Viatris Healthcare Limited |
| Arixtra 2,5 mg/0,5 ml, oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Viatris Healthcare Limited | |
| Arixtra 5 mg/0,4 ml, oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Viatris Healthcare Limited | |
| Arixtra 10 mg/0,8 ml, oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Viatris Healthcare Limited | |
| Arixtra 1,5 mg/0,3 ml, oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Viatris Healthcare Limited | |
| Arixtra 7,5 mg/0,6 ml, oplossing voor injectie | Netherlands | Oplossing voor injectie | Authorised | Viatris Healthcare Limited | |
| Arixtra | Canada | 2.5 MG / 0.5 ML | Solution | Marketed | Aspen Pharmacare Canada INC. |
| Arixtra | Canada | 7.5 MG / 0.6 ML | Solution | Marketed | Aspen Pharmacare Canada INC. |
| ARIXTRA SOLUTION FOR INJECTION 2.5 mg/0.5 ml | Singapore | 2.5 mg/0.5 ml | injection | Authorised | DCH Auriga Singapore |